Drug combo check: does pirfenidone change levels of new IPF pill?

NCT ID NCT06241560

Recruiting now Knowledge-focused Sponsor: Boehringer Ingelheim Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 32 times

Summary

This study looks at how pirfenidone, a common IPF medicine, changes the amount of a new drug called BI 1015550 in the blood. About 20 adults with IPF, aged 40 and older, will take one dose of BI 1015550, then pirfenidone for three weeks, and then another dose of BI 1015550. Researchers will compare blood levels to see if there is a drug interaction.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

LTD "Aversi clinic"
RECRUITING

Tbilisi, 160, Georgia

Contact Phone: •••-•••-•••• Email: •••••@•••••
LTD The First Medical Center
RECRUITING

Tbilisi, 0180, Georgia

Contact Phone: •••-•••-•••• Email: •••••@•••••
Renovatio Clinical-The Woodlands-69551
RECRUITING

The Woodlands, Texas, 77380, United States

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

IDIOPATHIC PULMONARY FIBROSIS